Surface bio‐engineering of polymeric nanoparticles (PNPs) has emerged as a cornerstone
in contemporary biomedical research, presenting a transformative avenue that can …

While classic vaccines have proved greatly efficacious in eliminating serious infectious
diseases, innovative vaccine platforms open a new pathway to overcome dangerous …

Cancer vaccines targeting tumor specific neoantigens derived from nonsynonymous
mutations of tumor cells have emerged as an effective approach to induce antitumor T cells …

Epitope peptides are not suitable for nasal administration immunity due to their poor
immunogenicity and low delivery efficiency. Here, we reported an intranasal self-assembled …

Immunotherapy has attracted wide attention because it can not only kill tumor cells but also
effectively prevent tumor recurrence. However, due to the poor efficacy of the monotherapy …

Background/Objectives: Community-acquired methicillin-resistant Staphylococcus aureus
(CA-MRSA) greatly complicates the treatment of skin and soft tissue infections (SSTI). It was …

Generating long-lived mucosal and systemic antibodies through respiratory immunization
with protective antigens encapsulated in nanoscale biodegradable particles could …

This chapter highlights the general characteristics of pathogen-and host-derived adjuvants,
their advantages and disadvantages, and their contribution to adaptive immunity. An …

EP67 is a second-generation, human C5a-derived decapeptide agonist of C5a receptor 1
(C5aR1/CD88) that selectively activates mononuclear phagocytes over neutrophils to …

Nanomedicine provides innovative strategies that had significantly improved drug and gene
delivery and allowed control over the engineering of therapeutics, diagnostics, vaccines …